Global neurology programme

Objectives

• Understand neurologists’ attitudes towards Multiple Sclerosis drug therapies
• Explore current usage of therapies across international markets
• Gather insight from a highly specialised and heavily researched medical audience
• Ensure representation across multiple countries and practice types

Methodology

This was a global healthcare research programme using telephone-based interviewing, supported by local-language fieldwork and market-specific methodology management. RONIN’s specialist healthcare team identified the most appropriate approach for each market and managed sub-quotas carefully to ensure complete and consistent data collection across the full study.

The study targeted neurologists across a wide range of countries and practice environments. Recruitment was initially based on the client’s own target list, with additional in-house desk research used to support coverage and help achieve the required sample.

Challenge

The study required engagement with a highly specialised and frequently researched medical audience within the restricted universe of the client’s target list. Ensuring strong coverage across multiple countries and practice types added further complexity, particularly where local market conditions required tailored fieldwork support.

How RONIN approached it

RONIN provided custom telephone support, with each interview conducted in the respondent’s local language to maximise engagement and data quality. The healthcare team managed market-level quotas closely and supplemented recruitment with in-house desk research where needed, helping to strengthen coverage and maintain progress across all markets.

Results

RONIN delivered 2,345 interviews across 27 countries over one year, exceeding the client’s original interview target by 15%. The programme gave the client a robust international dataset on neurologists’ attitudes and treatment usage, providing a strong basis for understanding market perspectives across multiple sclerosis care environments.